Insider Trading Alert - SPB, CYH And LRCX Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, May 23, 2014, 112 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $90.00 to $7,463,228.50.

Highlighted Stocks Traded by Insiders:

Spectrum Brands Holdings (SPB) - FREE Research Report

Lumley David R, who is CEO and President GB&PC H&G at Spectrum Brands Holdings, sold 10,000 shares at $74.81 on May 23, 2014. Following this transaction, the CEO and President GB&PC H&G owned 98,832 shares meaning that the stake was reduced by 9.19% with the 10,000-share transaction.

The shares most recently traded at $76.90, up $2.09, or 2.72% since the insider transaction. Historical insider transactions for Spectrum Brands Holdings go as follows:

  • 4-Week # shares bought: 6,180
  • 4-Week # shares sold: 10,000
  • 12-Week # shares bought: 6,180
  • 12-Week # shares sold: 30,000
  • 24-Week # shares bought: 7,180
  • 24-Week # shares sold: 50,900

The average volume for Spectrum Brands Holdings has been 206,400 shares per day over the past 30 days. Spectrum Brands Holdings has a market cap of $4.0 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are up 7.74% year-to-date as of the close of trading on Friday.

Spectrum Brands Holdings, Inc., together with its subsidiaries, operates as a consumer products company worldwide. The company operates through Global Batteries & Appliances, Global Pet Supplies, Home and Garden Business, and Hardware & Home Improvement segments. The stock currently has a dividend yield of 1.58%. The company has a P/E ratio of 45.8. Currently, there are 2 analysts who rate Spectrum Brands Holdings a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on SPB - FREE

TheStreet Quant Ratings rates Spectrum Brands Holdings as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, compelling growth in net income, solid stock price performance, impressive record of earnings per share growth and expanding profit margins. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Spectrum Brands Holdings Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Community Health Systems (CYH) - FREE Research Report

Portacci Michael T, who is Division President at Community Health Systems, sold 4,840 shares at $41.00 on May 23, 2014. Following this transaction, the Division President owned 38,083 shares meaning that the stake was reduced by 11.28% with the 4,840-share transaction.

The shares most recently traded at $42.27, up $1.27, or 3% since the insider transaction. Historical insider transactions for Community Health Systems go as follows:

  • 4-Week # shares sold: 4,840
  • 12-Week # shares sold: 7,055
  • 24-Week # shares sold: 17,055

The average volume for Community Health Systems has been 1.8 million shares per day over the past 30 days. Community Health Systems has a market cap of $4.9 billion and is part of the health care sector and health services industry. Shares are up 8.73% year-to-date as of the close of trading on Friday.

Community Health Systems, Inc., together with its subsidiaries, provides general and specialized hospital healthcare services to patients in the United States. Currently, there are 12 analysts who rate Community Health Systems a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CYH - FREE

TheStreet Quant Ratings rates Community Health Systems as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and poor profit margins. Get the full Community Health Systems Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Lam Research (LRCX) - FREE Research Report

Gottscho Richard A, who is Executive Vice President at Lam Research, sold 18,000 shares at $59.50 on May 23, 2014. Following this transaction, the Executive Vice President owned 55,981 shares meaning that the stake was reduced by 24.33% with the 18,000-share transaction.

The shares most recently traded at $61.50, up $2.00, or 3.25% since the insider transaction. Historical insider transactions for Lam Research go as follows:

  • 4-Week # shares sold: 18,383
  • 12-Week # shares sold: 95,484
  • 24-Week # shares sold: 148,250

The average volume for Lam Research has been 2.2 million shares per day over the past 30 days. Lam Research has a market cap of $9.8 billion and is part of the technology sector and electronics industry. Shares are up 11.31% year-to-date as of the close of trading on Friday.

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers plasma etch products that remove materials from the wafer to create the features and patterns of a device. The stock currently has a dividend yield of 1.19%. The company has a P/E ratio of 21.4. Currently, there are 13 analysts who rate Lam Research a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LRCX - FREE

TheStreet Quant Ratings rates Lam Research as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, attractive valuation levels and compelling growth in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Lam Research Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Dow Plunges on Trade War Worries but Walmart and Verizon Finish Positively

Dow Plunges on Trade War Worries but Walmart and Verizon Finish Positively

Tuesday Turnaround in Politics: Is a Trade War on the Horizon?

Tuesday Turnaround in Politics: Is a Trade War on the Horizon?

FANG Stocks Get Swept Up in Broader Market Selloff

FANG Stocks Get Swept Up in Broader Market Selloff

Snap Shares Plunge After Cowen Cuts Price Target

Snap Shares Plunge After Cowen Cuts Price Target

Netflix Shares Hit All-Time High as Market Flounders

Netflix Shares Hit All-Time High as Market Flounders